Serum Level of Antioxidant Enzymes in Opium-Addicted Patients With Coronary Artery Disease

Document Type: Original Article

Authors

Cardiovascular research center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences Kerman, IR. Iran.

Abstract

Background: Opiates cause coronary artery disease (CAD), which is one of the most common complicated cardiovascular diseases and is responsible for morbidity and mortality rates. The mechanism of the association between opiates and CAD is not well known. Therefore, the aim of this study was to evaluate antioxidant enzymes serum levels in patients with CAD and opium addiction.
Methods: This case-control study was performed on 188 cases (40 in the CAD group, 39 in the CAD and opium addiction group, and 60 in the control group). Superoxide dismutase (SOD) and glutathione peroxidase (GPx) were measured by enzymatic methods and compared between the groups.
Results: The serum level of SOD was 744.55 ± 506.16 U/L, which was lowest among the patients who had CAD with opium consumption (465.46 ± 67.8 U/L) and highest in the control group (1304.46 ± 545.69 U/L) (P < 0.001). Furthermore, the serum level of GPx was 1076.92 ± 778.28 U/L, which was lowest among the patients who had CAD with opium consumption (769.79 ± 506.77 U/L) and highest in the control group (1661.41 ± 615.11 U/L) (P < 0.001).
Conclusions: The serum levels of SOD and GPx were significantly lower in our CAD cases with opium addiction. Opiates cause oxidative stress. Pharmacological and psychiatric approaches can reduce the toxicological effects of opiates.

Keywords


1. Dickens C, Cherrington A, McGowan L.
Depression and health-related quality of life in
people with coronary heart disease: A
systematic review. Eur J Cardiovasc
Nurs. 2012;11:265275.
2. Zwadlo C, Meyer GP, Schieffer B, WesthoffBleck M. Anomalous intramural course of
coronary arteries in congenital heart diseasethree case reports and review of the
literature. Congenit Heart Dis. 2012;7:139144.
3. Mehra M, Somohano T, Choi M. Mandibular
fibular graft reconstruction with CAD/CAM
technology: A clinical report and literature
review. J Prosthet Dent. 2016;115:123128.
4. Khot UN, Khot MB, Bajzer CT, Sapp SK,
Ohman EM, Brener SJ, et al. Prevalence of
conventional risk factors in patients with
coronary heart
disease. JAMA. 2003;290(7):898904.
5. Fruchart JC, Nierman MC, Stroes ES, Kastelein
JJ, Duriez P. New risk factors for atherosclerosis
and patient risk
assessment. Circulation. 2004;109(23 Suppl
1):III159.
6. Blankenberg S, Rupprecht HJ, Bickel C,
Torzewski M, Hafner G, Tiret L, Smieja M,
Cambien F, Meyer J, Lackner KJ; AtheroGene
Investigators. Glutathione peroxidase
activity and cardiovascular events in patients wit
h coronary artery disease. N Engl J Med. 2003
Oct 23;349(17):1605-13.
7. Mohammadi A, Darabi M, Nasry M, SaabetJahromi MJ, Malek-Pour-Afshar R, Sheibani H.
Effect of opium addiction on lipid profile and
atherosclerosis formation in
hypercholesterolemic rabbits. Exp Toxicol
Pathol. 2009;61(2):1459.
8. Sadeghian S, Darvish S, Davoodi G, Salarifar
M, Mahmoodian M, Fallah N, et al. The
association of opium with coronary artery
disease. Eur J Cardiovasc Prev
Rehabil. 2007;14(5):7157.
9. Marmor M, Penn A, Widmer K, Levin RI,
Maslansky R. Coronary artery disease and
opioid use. Am J Cardiol. 2004;93(10):12957.
10. Saadat H. Z, Ghanemnia M, Namazi M. H, Safi
M, Vakili H, Dabbagh A, et al. Opium
Addiction Increases Interleukin 1 Receptor
Antagonist (IL-1Ra) in the Coronary Artery
Disease Patients. Plos one. 2012;7(9)
11. Karajibani M, Montazerifar F, Khazaei Feizabad
A. Study of Oxidants and Antioxidants in
Addicts, Int J High Risk Behav Addict. 2017;
6(2):e3505. doi: 10.5812/ijhrba.35057.
12. Flohe L, Gunzler WA. Assays of glutathione
peroxidase. Methods Enzymol 1984;105:114
21.
13. Soykut B1, Eken A, Erdem O, Akay C, Aydın
A, Çetin MK, Dilbaz N. Oxidative stress
enzyme status and frequency of micronuclei in
heroin addicts in Turkey. Toxicol Mech
Methods. 2013 Nov;23(9):684-8.
14. Zahmatkesh M, Kadkhodaee M, Salarian A,
Seifi B, Adeli S. Impact of opioids on oxidative
status and related signaling pathways: An
integrated view. JOM. 2017; 13(4): 1-12.
15. Cheng TY, Zhu Z, Masuda S, Morcos NC.
Effects of multinutrient supplementation on
antioxidant defense systems in healthy human beings. J Nutrition Biochem. 2001; 12(7): 388-
95
16. Moradi-Sardareh H, Mohammadi N, Oubari F,
Nikbakht MR, Hosseini KR, Farnoosh G, et al.
Biochemical factors, MDA levels and
Antioxidant activity in Opium addicted
Hamsters. In Res J Biol Sci . 2014; 3(2): 21-4
17. Lamsal M, Gautam N, Bhatta N, Toora BD,
Bhattacharya SK, Baral N. Evaluation of lipid
peroxidation product, nitrite and antioxidant
levels in newly diagnosed and two months
follow-up patients with pulmonary
tuberculosis. Southeast Asian J Trop Med Public
Health. 2007; 38(4): 695-703
18. Pacifici R, Fiaschi AI, Micheli L, Centini F,
Giorgi G, Zuccaro P, et al. Immunosuppression
and oxidative stress induced by acute and
chronic exposure to cocaine in rat. Int
Immunopharmacol. 2003; 3(4): 581-92
19. Devi BG, Chan AW. Impairment of
mitochondrial respiration and electron transport
chain enzymes during cocaine-induced hepatic
injury. Life Sci. 1997; 60(11): 849-55
20. Devi BG, Chan AW. Cocaine-induced
peroxidative stress in rat liver: antioxidant
enzymes and mitochondria. J Pharmacol Exp
Ther. 1996; 279(1): 359-66
21. Boess F, Ndikum-Moffor FM, Boelsterli UA,
Roberts SM. Effects of cocaine and its oxidative
metabolites on mitochondrial respiration and
generation of reactive oxygen species. Biochem
Pharmacol. 2000; 60(5): 615-23
22. Moritz F, Monteil C, Isabelle M, Bauer F,
Renet S, Mulder P, et al. Role of reactive
oxygen species in cocaine-induced cardiac
dysfunction. Cardiovasc Res. 2003; 59(4): 834-
43
23. Mohammadi A, Mirzaei F, Jamshidi M, Yari R,
Pak S, Sorkhani A, et al. The in vivo
biochemical and oxidative changes by ethanol
and opium consumption in Syrian hamsters. Int
J Biol. 2013; 5(4): 14